OSL 12.5% 0.7¢ oncosil medical ltd

Many supposedly "good" candidates consider payment of salary...

  1. 117 Posts.
    lightbulb Created with Sketch. 8
    Many supposedly "good" candidates consider payment of salary sufficient reason to take a role. Bills to pay, kids to educate, retirement to fund. Objectively, "senior hires" doesn't mean a lot. The skeptics could consider it a tactical hire, intended to (mis)lead the punters into believing regulatory approvals are imminent. But that would be illegal of course!

    Facts outweigh assumptions.

    FACT: The FDA issued a disapproval (rejection) letter for the December 2015 IDE in January 2016. There was no full disclosure. It exists. Ask for it.

    FACT: BSI rejections are relatively infrequent. There is no timeline for providing a response to BSI questions. Most companies are smart enough to know when to voluntarily withdraw to avoid an official rejection.

    FACT: OncoSil, under Daniel Kenny, has continually over promised and underdelivered on regulatory approvals. That's his personal 20 month record. The two Roger's personal records extend well beyond that.

    FACT: No objective scientific evidence exists to suggest OncoSil are any closer to regulatory approval than what existed 10 years ago.

    FACT: All objective scientific and regulatory evidence confirms OncoSil are no closer to regulatory approval than their predecessors were 10 years ago.

    FACT: No regulatory approval in history was attributable to the CEO's unfaultering belief/confidence/expectation that approval would be achieved in the "near-term".

    Fear not rejections, but absence of approvals and lack of full disclosure.


 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
-0.001(12.5%)
Mkt cap ! $31.31M
Open High Low Value Volume
0.8¢ 0.8¢ 0.7¢ $57.23K 7.448M

Buyers (Bids)

No. Vol. Price($)
49 22344187 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 3212282 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.